Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: DNANEXUS, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2024-09-09 to 2025-09-09
Current total value of award: $1051402.26
Description: DEVELOP PRISM HIGH-IMPACT PLATFORM PILOT FOR PRE- SUBMISSION VALIDATION OF ECTDS SUPPORTING SPONSOR-REVIEWER INTERACTION.